News

Stem cell therapy holds promise for the treatment of several diseases. Turning that promise into scalable stem cell cultures for therapeutic applications can be challenging. Bridging the gap between research and clinical-grade production requires rigorous process design and use of standardized materials.

We are proud to announce our new collaboration with Imperial College London’s MRes program in Experimental Biomolecular Sciences. This partnership speaks to our commitment to supporting the next generation of scientists through hands-on experience with high-quality primary cell culture tools and expert guidance.

Make sure your orders arrive on time by checking our holiday shipping schedule.

Discover our latest eBook, created with RegMedNet, featuring expert insights and clinical research on overcoming key challenges in adoptive cell therapy for solid tumors. Explore the future of personalized cancer treatment through peer-reviewed studies and practical applications.

PromoCell GmbH, a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, announces its entry into the Good Manufacturing Practice (GMP) field.

Allogeneic cell therapies offer off-the-shelf solutions that can benefit multiple patients from a single donor source. Read on to learn more.

Advances in immuno-oncology continue to transform cancer treatment, offering hope where traditional therapies have fallen short.

Our new BPE-free and xeno-free formulations allow researchers to obtain reliable data across a range of applications, from basic studies to translational research.

The integrity of the supply chain is a cornerstone of successful cell culture manufacturing. It directly influences product quality, regulatory compliance, and patient safety.